Literature DB >> 7503084

Iron overload in African Americans.

J C Barton1, C Q Edwards, L F Bertoli, T W Shroyer, S L Hudson.   

Abstract

PURPOSE: Iron overload unexplained by dietary or medicinal iron excess, transfusion, or sideroblastic anemia has been described infrequently in Americans of African descent. The purpose of this study was to characterize iron overload attributable to excessive iron absorption in African Americans. PATIENTS AND METHODS: In a community hematology and medical oncology practice during the interval 1990 to 1993, we identified and evaluated a series of cases comprised of 6 men and 1 woman, with a mean age of 55 +/- 14 (SD) years (range 33 to 69). Data on clinical features, serum iron parameters, liver and body iron stores, evaluations of anemia, human leukocyte antigen (HLA) typing, and family studies were analyzed.
RESULTS: Among our patients, the serum iron parameters were: iron concentration 26 +/- 13 mumol/L, transferrin saturation 59 +/- 21%, and ferritin concentration 1,588 +/- 1,053 micrograms/L. Clinical abnormalities observed included weakness and fatigue, decreased libido and impotence, hepatopathy, arthropathy, diabetes mellitus, hypogonadotrophic hypogonadism, and hyperpigmentation. Hepatic parenchymal cell iron deposits were increased in each of the 6 patients studied, and Kupffer cell iron deposits were prominent in 4. The occurrence of iron overload was verified by liver iron quantification and therapeutic phlebotomy. Four subjects had alpha-thalassemia minor; 2 others had hemoglobin S and C traits. No proband had HLA-A3 positivity. Four probands had other family members with iron overload.
CONCLUSIONS: In comparison with Caucasians with hemochromatosis, our patients have slightly lower mean values of serum iron concentration and transferrin saturation, more Kupffer cell iron deposits, a higher incidence of thalassemia and hemoglobinopathy, and infrequent positivity for HLA-A3. Iron overload in African Americans appears to be more similar to that in certain sub-Saharan African natives than to hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503084     DOI: 10.1016/s0002-9343(99)80248-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

1.  Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled.

Authors:  J E Haddow; L A Bradley
Journal:  BMJ       Date:  1999-08-28

2.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  Elevated serum transferrin saturation and mortality.

Authors:  Arch G Mainous; James M Gill; Peter J Carek
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

4.  An unusual case of hemochromatosis in an African-American man: case report and review of the literature.

Authors:  David A Labowitz; Jennifer Bontreger; Albert D Min
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

5.  SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.

Authors:  James C Barton; Ronald T Acton; Pauline L Lee; Carol West
Journal:  Blood Cells Mol Dis       Date:  2007-05-09       Impact factor: 3.039

Review 6.  Forging a field: the golden age of iron biology.

Authors:  Nancy C Andrews
Journal:  Blood       Date:  2008-07-15       Impact factor: 22.113

7.  Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Charles A Rivers; James C Barton; Victor R Gordeuk; Ronald T Acton; Mark R Speechley; Beverly M Snively; Catherine Leiendecker-Foster; Richard D Press; Paul C Adams; Gordon D McLaren; Fitzroy W Dawkins; Christine E McLaren; David M Reboussin
Journal:  Blood Cells Mol Dis       Date:  2007-02-05       Impact factor: 3.039

Review 8.  Optimal management strategies for chronic iron overload.

Authors:  James C Barton
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Inter-ethnic differences in genetic variants within the transmembrane protease, serine 6 (TMPRSS6) gene associated with iron status indicators: a systematic review with meta-analyses.

Authors:  Wanjiku N Gichohi-Wainaina; G Wayne Towers; Dorine W Swinkels; Michael B Zimmermann; Edith J Feskens; Alida Melse-Boonstra
Journal:  Genes Nutr       Date:  2014-11-22       Impact factor: 5.523

10.  The mortality risk of elevated serum transferrin saturation and consumption of dietary iron.

Authors:  Arch G Mainous; Brian Wells; Peter J Carek; James M Gill; Mark E Geesey
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.